1\. To develop a multiactivity training programme. 2. To explore the effect of this programme on sarcopenia, sarcopenic obesity, cognitive impairment and Parkinson's disease. 3. To compare the effects of the experimental and control treatments on the muscle strength, body composition, physical function performance and quality of life of the elderly.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Chang in muscle strength from baseline to 16 weeks
Timeframe: Baseline and 16 weeks
Chang in weight of muscle and fat from baseline to 16 weeks
Timeframe: Baseline and 16 weeks
Chang in Activities of Daily Living from baseline to 16 weeks
Timeframe: Baseline and 16 weeks
Chang in Instrumental activities of daily living from baseline to 16 weeks
Timeframe: Baseline and 16 weeks
Chang in Clinical Dementia Rating from baseline to 16 weeks
Timeframe: Baseline and 16 weeks
Chang in Cornell Scale for Depression in Dementia from baseline to 16 weeks
Timeframe: Baseline and 16 weeks
Chang in Cohen-Mansfield Agitation Inventory from baseline to 16 weeks
Timeframe: Baseline and 16 weeks
Chang in EQ5D from baseline to 16 weeks
Timeframe: Baseline and 16 weeks
Chang in QUALIDEM from baseline to 16 weeks
Timeframe: Baseline and 16 weeks
Demographic attributes
Timeframe: Baseline
Chang in PERSONAL WELLBEING INDEX from baseline to 16 weeks
Timeframe: Baseline and 16 weeks
Chang in PERSONAL WELLBEING INDEX intellectual disability from baseline to 16 weeks
Timeframe: Baseline and 16 weeks.
Chang in World Health Organization Quality of Life Instruments (WHOQOL-BREF) from baseline to 16 weeks
Timeframe: Baseline and 16 weeks.
Chang in Four-Meter Gait Speed from baseline to 16 weeks
Timeframe: Baseline and 16 weeks.